glp 1 ra Indications for GLP-1/GIP Summary Sheet and Beyond! Rethinking GLP-1RA Therapy Through the

Most providers require a BMI of 30+ (or 27+ with a weight-related condition), a medical history review, and sometimes lab work

Note that exenatide and lixisenatide are contraindicated in patients with renal dysfunction (for details see Contraindications section)

Small molecule GLP-1 agonists and antagonists (such as those in development at Structure Therapeutics) may facilitate study of endogenous GLPs activity and increase clinical uptake in T2D and obesity patients

Some plans cover brand-name medications (Wegovy, Zepbound) prescribed via telehealth, though prior authorization is typically required

[DOI] [Google Scholar] 278.Javaid A., Baviriseaty S., Javaid R., Zirikly A., Kukreja H., Kim C.H., Blaha M.J., Blumenthal R.S., Martin S.S., Marvel F.A

Naturally sweet, zero added sugar